Canbridge Pharmaceuticals Inc To Issue Aggregate Of 84 Million Subscription Shares
ReutersFeb 16, 2026 1:29 AM
Feb 16 (Reuters) - Canbridge Pharmaceuticals Inc 1228.HK:
TO ISSUE AGGREGATE OF 84 MILLION SUBSCRIPTION SHARES AT HK$2.38 PER SHARE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Should You Invest in the “Magnificent Seven” in 2026? One Stock or All of Them?
TradingKey - The Magnificent Seven defined markets in 2024 and remained at the heart of the 2025 story. Collectively, they have unparalleled control over AThe Magnificent Seven includes Nvidia (NVDA), Apple (AAPL), Alphabet (GOOG) (GOOGL), Microsoft (MSFT), Amazon (AMZN), Meta Platforms (META), andTradingKey
4 hours ago
SpaceX IPO with Dual-Class Shares: Will Musk Secure the 25% Voting Control Denied by Tesla?
TradingKey - SpaceX is preparing for an IPO this year. According to foreign media reports, SpaceX is considering a dual-class share structure for its IPO, which would grant specific shareholders extra voting rights. In other words, Elon Musk could maintain absolute control over the company even if hTradingKey
Sat, Feb 14
Bitcoin Price Prediction 2029-2035: Institutional Accumulation and the U.S. Treasury’s Strategic Reserve Pivot
Explore the 2026 Bitcoin landscape: From the U.S. Strategic Reserve and Michael Saylor’s $75B war chest to Cathie Wood’s 2030 forecast. Is BTC the new Digital Gold?TradingKey
Fri, Feb 13
Is SaaS Dead? The Truth Behind the Software Meltdown, the Missing Floor, and the Peak That’s Not Coming Back
TradingKey - A trillion dollars just vanished from software stocks—this piece breaks down who AI is really killing, who quietly benefits, and why cheap SaaS may be the biggest value trap of this cycle.TradingKey
Thu, Feb 12
